BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

NovaDigm Therapeutics  

4201 James Ray Drive
REAC 1 Building, Suite 2200
Grand Forks  North Dakota  58202  U.S.A.
Phone: 701-757-5161 Fax: 701-335-7121


SEARCH JOBS



Segment
Pharmaceuticals





 Company News
NovaDigm Therapeutics Raises $14 Million Series B to Support Phase 2 Trial of NDV-3 Vaccine Against Candida 10/3/2013 7:14:56 AM    More...
NovaDigm Therapeutics Initiates Phase 1b/2a Clinical Trial with NDV-3 Vaccine in Recurrent Vulvovaginal Candidiasis (RVVC) 9/26/2013 9:55:58 AM    More...
Results From Positive Phase 1 Study of NovaDigm Therapeutics ’ NDV-3 Vaccine for Candida and Staph Infections Published in Vaccine 12/13/2012 10:12:39 AM    More...
Pfizer Inc. (PFE), GlaxoSmithKline (GSK) and NovaDigm Therapeutics ' Vaccine for Staph More Lethal Than Skin Cancer Tested 9/17/2012 8:01:15 AM    More...
NovaDigm Therapeutics Presents Positive Safety and Immunogenicity Data in a Second Phase 1 Study for NDV-3 Vaccine 5/7/2012 9:52:42 AM    More...
NovaDigm Therapeutics Presents Positive Preclinical Data in Vulvovaginal Candidiasis for NDV-3 Vaccine 9/19/2011 7:16:53 AM    More...
NovaDigm Therapeutics to Present Positive Clinical and Preclinical Data for NDV-3 Vaccine at ICAAC 9/12/2011 10:20:04 AM    More...

//-->